Invasion and intracellular survival of Burkholderia cepacia

Infection and Immunity

Volumn 68, Issue 1, 2000, Pages 24-29

  Martin, Daniel W ^a   Mohr, Christian D ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRULENCE FACTOR;

ARTICLE; BACTERIAL TRANSLOCATION; BACTERIAL VIRULENCE; BACTERIUM COMPETENCE; BURKHOLDERIA CEPACIA; CELL INCLUSION; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033964725     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.1.24-29.2000     Document Type: Article

References (29)

1. Bellinger-Kawahara, C., and M. A. Horwitz. 1990. Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes. J. Exp. Med. 172:1201-1210.
2. Burns, J., M. Jonas, E. Chi, D. Clark, A. Berger, and A. Griffith. 1996. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect. Immun. 64:4054-4059.
3. Butler, S., C. Doherty, J. Hughes, J. Nelson, and J. Govan. 1995. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J. Clin. Microbiol. 33:1001-1004.
4. Finlay, B., and S. Falkow. 1997. Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 61:136-169.
5. Gold, R., E. Jin, H. Levinson, A. Isles, and P. C. Fleming. 1983. Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J. Antimicrob. Chemother. 12:331-336.
6. Goldstein, J. L., R. G. W. Anderson, and M. S. Brown. 1979. Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 279:679-685.
7. Govan, J. R. W., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 68:539-574.
8. Govan, J. R. W., and J. Nelson. 1992. Microbiology of lung infection in cystic fibrosis. Br. Med. Bull. 48:912-930.
9. Hutchison, M., I. Poxton, and J. Govan. 1998. Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect. Immun. 66:2033-2039.
10. Isberg, R. R., and S. Falkow. 1985. A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature (London) 317:262-264.
11. Isles, A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming, and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206-210.
12. Johnson, W., S. Tyler, and K. Rozee. 1994. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J. Clin. Microbiol. 32:924-930.
13. Kaufmann, S. H. E. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129-163.
14. Lewin, C., C. Doherty, and J. W. R. Govan. 1993. In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, cotrimoxazole, and ciprofloxacin against Pseudomonas cepacia. Antimicrob. Agents Chemother. 37:123-125.
15. Mahenthiralingam, E., M. Campbell, D. Henry, and D. Speert. 1996. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J. Clin. Microbiol. 34:2914-2920.
16. Monack, D., B. Raupach, A. Hromockyj, and S. Falkow. 1996. Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc. Natl. Acad. Sci. USA 93:9833-9838.
17. Nelson, J. W., S. L. Butler, P. H. Brown, A. P. Greening, and J. R. W. Govan. 1993. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis. J. Med. Microbiol. 39:39-47.
18. Palfreyman, R., M. Watson, C. Eden, and A. Smith. 1997. Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products. Infect. Immun. 65:617-622.
19. Pascopella, L., B. Raupach, N. Ghori, D. Monack, S. Falkow, and P. L. C. Small. 1995. Host restriction phenotypes of Salmonella typhi and Salmonella gallinarum. Infect. Immun. 63:4329-4335.
20. Pitt, T., M. Kaufmann, P. Patel, L. Benge, S. Gaskin, and D. Livermore. 1996. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J. Med. Microbiol. 44:203-210.
21. Prince, A. 1986. Antibiotic resistance of Pseudomonas species. J. Pediatr. 108:830-834.
22. Rosenstein, B. J., and D. E. Hall. 1980. Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis. John Hopkins Med. J. 147:188-189.
23. Schlesinger, L. S., and M. A, Horwitz. 1994. A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes. Infect. Immun. 62:280-289.
24. Speert, D., M. Bond, R. Woodman, and J. Curnutte. 1994. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. J. Infect. Dis. 170:1524-1531.
25. Sun, L., R. Jiang, S. Steinbach, A. Holmes, C. Campanelli, J. Forstner, U. Sajjan, Y. Tan, M. Riley, and R. Goldstein. 1995. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nature Medicine. 1:661-666.
26. Wieczorek, R., A. Steinbuchel, and B. Schmidt. 1996. Occurrence of polyhydroxyalkanoic acid granule-associated proteins related to the Alcaligenes eutrophus H16 GA24 protein in other bacteria. FEMS Microbiol. Lett. 135: 23-30.
27. Zughaier, S. M., H. C. Ryley, and S. K. Jackson. 1999. A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide anion. Infect. Immun. 67:908-913.
28. Zychlinsky, A., B. Kenny, R. Menard, M. Prevost, I. Holland, and P. Sansonetti. 1994. IpaB mediates macrophage apoptosis induced by Shigella flexneri. Mol. Microbiol. 11:619-627.
29. Zychlinsky, A., and P. Sansonetti. 1997. Apoptosis in bacterial pathogenesis. J. Clin. Investig. 100:S63-S65.